Federal legislation to legalize, regulate, and tax cannabis could have significant impacts on the federal budget.
In a new white paper, Alex Brill details the consequences of regulatory uncertainty for businesses and provides a close look at the ongoing uncertainty facing companies owned by ESOPs.
MGA latest white paper, by CEO Alex Brill, looks at the role of pharmacy benefit managers (PBMs) in the US prescription drug market.
MGA’s state-by-state analysis of Community Health Centers’ economic impact.
MGA has released a new report today for the Coalition for Affordable Prescription Drugs (CAPD), “Patent Thickets and Lost Drug Savings.”
The Biosimilars Council released the following statement in response to the new MGA report authored by Alex Brill and Christy Robinson.